Outset Medical, Inc.OMEarnings & Financial Report
Nasdaq · Health Care · Electromedical & Electrotherapeutic Apparatus
Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Ameriprise Financial, | 10.12% | 5.1M | ▲ +4.18pp | 2024-04-10 |
| FMR LLC | 9.16% | 4.8M | ▼ -4.91pp | 2024-11-12 |
| T. Rowe Price Investment Management, Inc. | 6.30% | 3.2M | — | 2024-02-14 |
| The Vanguard Group | 5.07% | 2.6M | flat | 2024-11-12 |
| Millennium Management LLC | 3.60% | 1.9M | ▼ -1.90pp | 2024-11-12 |
| Bellevue Group AG | 3.50% | 1.8M | — | 2024-02-13 |
| S.S. or | 3.37% | 1.8M | — | 2024-09-10 |
| BlackRock, Inc. | 1.70% | 880.5K | ▼ -5.90pp | 2024-07-08 |
| NOS. OF ABOVE PERSONS | 0.20% | 134.8K | ▼ -9.20pp | 2024-09-05 |
Insider Transactions
Net 90d: −$26.9K · buys $0 / sells $26.9KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-06 | Elliott Derick A. | EVP, Commercial | Grant | 96.0K | $0.00 | $0 |
| 2026-02-17 | Brottem John L. | General Counsel | Sell (open market) | 2.8K | $3.35 | $9.5K |
| 2026-02-17 | Leslie Trigg | Chair and CEO | Sell (open market) | 3.4K | $3.35 | $11.3K |
| 2026-02-17 | Marc Nash | EVP Operations R&D & Service | Sell (open market) | 1.8K | $3.35 | $6.1K |
1–4 of 4